Percutaneous iliac artery stent: angiographic long-term follow-up.

Radiology

Cardiovascular Radiology Service, Hôpital Broussais, Paris, France.

Published: September 1991

The authors conducted a prospective study of 49 consecutive patients with 53 lesions in 52 iliac arteries. All were treated between October 1987 and April 1990 with percutaneous transluminal angioplasty (PTA) and insertion of either a self-expandable or balloon-expandable stent. Lesions included total occlusion (28%), dissection (42%), post-PTA restenosis (21%), and unsatisfactory PTA (9%). Complications included one aortic protrusion, one acute thrombosis of the stent (resolved with urokinase), and three distal embolizations (5.7%) (resolved with urokinase and aspiration). During 15 months of follow-up, two patients died (one after occlusion). Three other occlusions occurred; one of these was resolved with local thrombolysis. Hyperplasia occurred in seven cases (13.5%), and stenosis occurred at the end of the stent because of incomplete covering of the lesion in three (5.8%); a complementary procedure was performed in six of these cases. Primary patency was 85.3% at 12 months and 80.9% at 18 months; secondary patency rate was 96.1% at 12 and at 18 months. At the end of the study, excluding data for the two patients who died, 27 limbs (54%) were asymptomatic and improvement was achieved in 19 (38%); the clinical success rate was 92%. No amputations were required.

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiology.180.3.1831274DOI Listing

Publication Analysis

Top Keywords

resolved urokinase
8
patients died
8
percutaneous iliac
4
iliac artery
4
stent
4
artery stent
4
stent angiographic
4
angiographic long-term
4
long-term follow-up
4
follow-up authors
4

Similar Publications

Purpose: Acute lower limb ischemia (ALI) is a sudden decrease in arterial limb perfusion due to an arterial blockage, threatening limb and life. Catheter-directed thrombolysis (CDT) is a minimally invasive procedure to remove such obstructions. However, approximately one-third of patients endure a re-occlusion after successful CDT.

View Article and Find Full Text PDF

Regulation of macrophage fibrinolysis during venous thrombus resolution.

Thromb Res

November 2024

Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, MD 21201, USA; Department of Physiology, University of Maryland School of Medicine, Baltimore, MD 21201, USA; Research & Development Service, VA Maryland Health Care System, Baltimore, MD, 21201, USA. Electronic address:

Background: Venous thromboembolism (VTE), which includes pulmonary embolism (PE) and deep vein thrombosis (DVT), is a serious cardiovascular disease with significant mortality and morbidity. Clinically, patients with faster resolution of a venous thrombi have improved prognosis. Urokinase-plasminogen activator (uPA), produced by macrophages, is a key mediator of fibrinolysis required for resolving venous thrombi and restoring vascular integrity.

View Article and Find Full Text PDF

Intrapleural Fibrinolytic Interventions for Retained Hemothoraces in Rabbits.

Int J Mol Sci

August 2024

Department of Cellular and Molecular Biology, School of Medicine, The University of Texas Health Science Center at Tyler, 11937 US HWY 271, Tyler, TX 75708, USA.

Article Synopsis
  • Bleeding in the pleural space can lead to retained hemothorax (RH), causing lung issues and shortness of breath due to clot formation.
  • Researchers tested single-chain urokinase (scuPA) for intrapleural clot dissolution in a rabbit model, comparing its effectiveness against another agent, single-chain tissue plasminogen activator (sctPA).
  • Results indicated that delivering two doses of scuPA was more effective than a single higher dose, and both agents were equally capable of clearing clots and promoting fluid drainage, though more clinical trials are needed to determine the best treatment approach.
View Article and Find Full Text PDF

Introduction: Persistent withdrawal occlusion (PWO) is a specific catheter malfunction characterized by the inability to withdraw blood through the device. The most common cause of PWO in ports is the presence of a fibroblastic sleeve (FS). If malfunction occurs, medication can be applied incorrectly with the increased risk of complications.

View Article and Find Full Text PDF

The autoactivation of human single-chain urokinase-type plasminogen activator (uPA).

J Biol Chem

October 2023

Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California, USA. Electronic address:

Most serine proteases are synthesized as inactive zymogens that are activated by cleavage by another protease in a tightly regulated mechanism. The urokinase-type plasminogen activator (uPA) and plasmin cleave and activate each other, constituting a positive feedback loop. How this mutual activation cycle begins has remained a mystery.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!